China Medicine Corporation (CHME)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
At close: May 30, 2025
China Medicine Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | 2003 - 2004 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '10 Sep 30, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | 2003 - 2004 |
Cash & Equivalents | 7.85 | 0.47 | 2.79 | 5.77 | 0.37 | 0.09 | Upgrade
|
Cash & Short-Term Investments | 7.85 | 0.47 | 2.79 | 5.77 | 0.37 | 0.09 | Upgrade
|
Cash Growth | 250.22% | -83.10% | -51.60% | 1452.65% | 303.94% | -62.24% | Upgrade
|
Accounts Receivable | 17.27 | 22.31 | 19.23 | 13.63 | 7.03 | 2.41 | Upgrade
|
Receivables | 17.27 | 22.32 | 19.83 | 13.63 | 7.03 | 2.41 | Upgrade
|
Inventory | 5.87 | 2.73 | 4.73 | 3.95 | 1.9 | 1.38 | Upgrade
|
Restricted Cash | 48.47 | 1.76 | - | - | - | - | Upgrade
|
Other Current Assets | 14.73 | 2.98 | 6.31 | 6.06 | 3.17 | 1.11 | Upgrade
|
Total Current Assets | 94.2 | 30.26 | 33.66 | 29.41 | 12.48 | 5 | Upgrade
|
Property, Plant & Equipment | 15.94 | 12 | 3.76 | 1.39 | 1.22 | 0.33 | Upgrade
|
Other Intangible Assets | 16.64 | 16.68 | 1.25 | 1.17 | 0.13 | - | Upgrade
|
Long-Term Deferred Charges | 0.45 | 0.07 | 0.15 | - | 0.95 | - | Upgrade
|
Other Long-Term Assets | 6.82 | 7.83 | 5.86 | 0.68 | - | - | Upgrade
|
Total Assets | 134.05 | 66.84 | 44.68 | 32.64 | 14.77 | 5.33 | Upgrade
|
Accounts Payable | 0.86 | 1.32 | 0.06 | 0.08 | 0.19 | 0.17 | Upgrade
|
Accrued Expenses | 0.39 | 1.46 | 0.76 | 0.41 | 0.31 | 0.17 | Upgrade
|
Short-Term Debt | 4.05 | 9.51 | - | - | - | 0.1 | Upgrade
|
Current Income Taxes Payable | 1.45 | 0.66 | 0.01 | 0.06 | -0.01 | - | Upgrade
|
Current Unearned Revenue | 0.65 | 0.48 | 0.15 | 0.2 | 0.02 | 0.04 | Upgrade
|
Other Current Liabilities | 1.05 | 0.98 | 0.09 | 0.11 | 0.1 | 0.1 | Upgrade
|
Total Current Liabilities | 8.45 | 14.42 | 1.08 | 0.86 | 0.6 | 0.57 | Upgrade
|
Other Long-Term Liabilities | 0.07 | 6.92 | - | - | - | - | Upgrade
|
Total Liabilities | 8.52 | 21.34 | 1.08 | 0.86 | 0.6 | 0.57 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 41.32 | 13.38 | 13.01 | 12.56 | 4.4 | 0.12 | Upgrade
|
Retained Earnings | 29.15 | 27.17 | 25.33 | 16.2 | 9.32 | 4.54 | Upgrade
|
Comprehensive Income & Other | 7.35 | 4.44 | 4.43 | 2.12 | -0.46 | 0.1 | Upgrade
|
Total Common Equity | 77.63 | 44.99 | 42.77 | 30.88 | 13.26 | 4.76 | Upgrade
|
Minority Interest | 0.29 | 0.52 | 0.84 | 0.89 | 0.91 | - | Upgrade
|
Shareholders' Equity | 125.52 | 45.51 | 43.6 | 31.78 | 14.17 | 4.76 | Upgrade
|
Total Liabilities & Equity | 134.05 | 66.84 | 44.68 | 32.64 | 14.77 | 5.33 | Upgrade
|
Total Debt | 4.05 | 9.51 | - | - | - | 0.1 | Upgrade
|
Net Cash (Debt) | 3.81 | -9.03 | 2.79 | 5.77 | 0.37 | -0 | Upgrade
|
Net Cash Growth | - | - | -51.60% | 1452.65% | - | - | Upgrade
|
Net Cash Per Share | 0.12 | -0.59 | 0.18 | 0.42 | 0.05 | -0.00 | Upgrade
|
Filing Date Shares Outstanding | 39.49 | 20.43 | 15.23 | 14.82 | 8.16 | 6.53 | Upgrade
|
Total Common Shares Outstanding | 39.49 | 15.45 | 15.23 | 14.82 | 8.16 | 6.53 | Upgrade
|
Working Capital | 85.75 | 15.84 | 32.58 | 28.54 | 11.88 | 4.43 | Upgrade
|
Book Value Per Share | 1.97 | 2.91 | 2.81 | 2.08 | 1.63 | 0.73 | Upgrade
|
Tangible Book Value | 61 | 28.31 | 41.52 | 29.72 | 13.13 | 4.76 | Upgrade
|
Tangible Book Value Per Share | 1.54 | 1.83 | 2.73 | 2.01 | 1.61 | 0.73 | Upgrade
|
Buildings | 4.81 | 5.09 | 0.32 | - | - | - | Upgrade
|
Machinery | 8.69 | 7.71 | 4.36 | 1.84 | 1.51 | 0.66 | Upgrade
|
Construction In Progress | 7.35 | 3.05 | - | - | - | - | Upgrade
|
Leasehold Improvements | - | - | - | 0.18 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.